Agenus Inc - May 1, 2023 Form 4/A - Amendment Insider Report for MiNK Therapeutics, Inc. (INKT)

Role: 10%+ Owner
Signature: /s/ Christine Klaskin, Vice President, Finance
Stock symbol: INKT
Transactions as of: May 1, 2023
Transactions value $: $0
Form type: 4/A - Amendment
Date filed: 5/26/2023, 05:12 PM
Date Of Original Report: May 3, 2023
Previous filing: Oct 20, 2021
Next filing: May 5, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	INKT	Common Stock	Other	$0	-5.01M	-19.01%	$0.00	21.3M	May 1, 2023	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On May 1, 2023, Agenus Inc. ("Agenus") paid its previously announced pro rata stock dividend (the "Dividend") consisting of an aggregate of 5,006,397 shares of common stock of MiNK Therapeutics, Inc. ("MiNK") held by Agenus (the "Dividend Shares") to record holders of Agenus's common stock as of April 17, 2023 (the "Record Date"). Agenus distributed 0.0146 of a share of MiNK's common stock for each share of Agenus's common stock outstanding as of the close of business on the Record Date. No fractional shares were issued in connection with the Dividend and the equityholders of Agenus who were entitled to receive fractional shares of the Dividend Stock received cash (without interest) in lieu of such fractional shares.
F2	The Form 4 filed by Agenus on May 3, 2023 inadvertently underreported the number of Dividend Shares distributed to record holders of Agenus's common stock as of the Record Date by 18,316 shares.

Content

On May 1, 2023, Agenus Inc. ("Agenus") paid its previously announced pro rata stock dividend (the "Dividend") consisting of an aggregate of 5,006,397 shares of common stock of MiNK Therapeutics, Inc. ("MiNK") held by Agenus (the "Dividend Shares") to record holders of Agenus's common stock as of April 17, 2023 (the "Record Date"). Agenus distributed 0.0146 of a share of MiNK's common stock for each share of Agenus's common stock outstanding as of the close of business on the Record Date. No fractional shares were issued in connection with the Dividend and the equityholders of Agenus who were entitled to receive fractional shares of the Dividend Stock received cash (without interest) in lieu of such fractional shares.

The Form 4 filed by Agenus on May 3, 2023 inadvertently underreported the number of Dividend Shares distributed to record holders of Agenus's common stock as of the Record Date by 18,316 shares.